Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review

OBJECTIVE: To assess the efficacy and safety of tocilizumab (TCZ) in Caucasian patients with refractory Takayasu’s arteritis (TAK) in clinical practice. METHODS: A multicenter study of Caucasian patients with refractory TAK who received TCZ. The outcome variables were remission, glucocorticoid-spari...

Descripción completa

Detalles Bibliográficos
Autores principales: Prieto-Peña, Diana, Bernabeu, Pilar, Vela, Paloma, Narváez, Javier, Fernández-López, Jesús C., Freire-González, Mercedes, González-Álvarez, Beatriz, Solans-Laqué, Roser, Callejas Rubio, José L., Ortego, Norberto, Fernández-Díaz, Carlos, Rubio, Esteban, García-Morillo, Salvador, Minguez, Mauricio, Fernández-Carballido, Cristina, de Miguel, Eugenio, Melchor, Sheila, Salgado, Eva, Bravo, Beatriz, Romero-Yuste, Susana, Salvatierra, Juan, Hidalgo, Cristina, Manrique, Sara, Romero-Gómez, Carlos, Moya, Patricia, Álvarez-Rivas, Noelia, Mendizabal, Javier, Ortiz-Sanjuán, Francisco, Pérez de Pedro, Iván, Alonso-Valdivielso, José L., Perez-Sanchez, Laura, Roldán, Rosa, Fernandez-Llanio, Nagore, Gómez de la Torre, Ricardo, Suarez, Silvia, Montesa Cabrera, María Jesús, Delgado Sánchez, Mónica, Loricera, Javier, Atienza-Mateo, Belén, Castañeda, Santos, González-Gay, Miguel A., Blanco, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216399/
https://www.ncbi.nlm.nih.gov/pubmed/34211589
http://dx.doi.org/10.1177/1759720X211020917

Ejemplares similares

Ejemplares similares